AzTrials
AzTrials

Temporomandibular Disorders (TMD)NCT06871189

Age and Gender in TMJ Sounds

An observational study of Temporomandibular Disorders (TMD), run by Atlas University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The temporomandibular joint (TMJ) plays a crucial role in masticatory function, and its proper lubrication is essential for smooth, frictionless movement. Disruptions to the lubricating system, often due to age-related changes or parafunctional activities such as teeth clenching or bruxism, can increase joint… Read more about this study

Who is it for?
Ages 10 to 30 years
Conditions the study is for
Temporomandibular Disorders (TMD)
How many people
300 participants
Where
1 siteTurkey (Türkiye)
Study dates
8 Dec 2024to 5 Mar 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 30 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: free of symptoms related to temporomandibular disorder

Who may be able to join

  • Participants capable of achieving an inter-incisal opening of 30 to 50 mm without restrictions.
  • Free from symptoms indicative of temporomandibular disorder (TMD).
  • Possessing fully and/or prosthetically restored dentition.
  • Demonstrating adequate mouth opening to facilitate the rotation of the condylar process.

Who cannot join

  • Individuals using psychotropic or narcotic medications, regardless of medical oversight.
  • Regular consumption of painkillers or anti-inflammatory agents.
  • Long-term treatment with cortisone or its derivatives. Individuals who have sustained traumatic injuries to the maxillofacial region.
  • Participants who have suffered the loss of organs and/or tissue in the maxillofacial area due to medical or traumatic causes.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Istanbul Atlas Univercity

    Istanbul, Anadolu, 34403

Other trials in Turkey (Türkiye)

About this study

Official title: Age and Gender on TMJ Sound Frequencies and Mouth-Opening Distances

The temporomandibular joint (TMJ) plays a crucial role in masticatory function, and its proper lubrication is essential for smooth, frictionless movement. Disruptions to the lubricating system, often due to age-related changes or parafunctional activities such as teeth clenching or bruxism, can increase joint friction, leading to vibrations or intra-articular sounds. These sounds have become an essential diagnostic tool for assessing internal derangements of the TMJ. While magnetic resonance imaging (MRI) is considered the gold standard for diagnosing TMJ disorders, its limitations in evaluating intra-articular structures have led to the development of alternative methods, such as Joint Vibration Analysis (JVA). This study explores the relationship between age, gender, and TMJ vibration frequencies using JVA in a cohort of 367 participants. We analyzed four key vibration parameters: Range of Motion (ROM), Total Integral Left (TIL), Total Integral Right (TIR), and frequency distributions in the <300 Hz and >300 Hz segments.

Keywords
age, gender, temporomandibular disorders, vibration frequencies
Medical subject headings
Temporomandibular Joint Disorders, Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06871189
Study groupRoleWhat they receive
Female ≤22 yearsParticipants who identify as female and are 22 years old or younger.
Female ≥23 yearsParticipants who identify as female and are 23 years old or older.
Male ≤22 yearsParticipants who identify as male and are 22 years old or younger.
Male ≥23 yearsParticipants who identify as male and are 23 years old or older.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. range of motion

    ROM is measured as the maximum mouth opening (mouth opening distance), which is an indicator of joint mobility and dysfunction in TMD patients. Limited or abnormal ROM in the TMJ, reflected by restricted mouth opening, is often associated with pain, dysfunction, and impaired jaw movement, making it a crucial parameter for assessing the severity of TMD.

    Measured: The outcome measure was assessed at baseline.

  2. Total Integral

    hese parameters assess the intensity and frequency of the joint's movement on each side (left and right). TIL and TIR represent the overall activity and functional performance of the TMJ during movement, with abnormal values potentially indicating dysfunction or asymmetry between the left and right sides. These parameters are critical for evaluating the joint's response to treatment and the presence of any abnormalities in movement or pressure distribution across the TMJ.

    Measured: The outcome measure was assessed at baseline

  3. Frequency Components

    The frequency parameters assess the overall movement and condition of the temporomandibular joint (TMJ) by measuring pressure wave activity across different frequency ranges. Integral > 300 Hz (d1/d2) reflects higher frequency components primarily influenced by joint surface roughness and degenerative changes. Integral < 300 Hz (c1/c2) represents lower frequency components associated with disc movements, which can be affected by disc displacement, hypermobility, or joint laxity. The Ratio (e1/e2) indicates the ratio of high to low frequencies, providing insight into joint surface condition and overall TMJ health. These parameters are crucial for evaluating the function and possible degeneration of the TMJ.

    Measured: The outcome measure was assessed at baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2025
  2. Study start8 Dec 2024
  3. Primary completion5 Mar 2025
  4. Study completion5 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06871189
Sponsor's protocol ID
2024-ATLAS
Status last verified
Feb 2025
First submitted
28 Feb 2025
Last updated
11 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Temporomandibular Disorders (TMD), run by Atlas University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

range of motion (time frame: The outcome measure was assessed at baseline.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in